ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
BERLIN, Oct. 20, 2025 /PRNewswire/ — At the 2025 European Society for…
October 20, 2025
JSBC Unveils "Chinese Wisdom" Book Series for Global Audiences